Vitamin D and its role in human milk oligosaccharide production.

What Was Tested

This randomized controlled trial looks at Vitamin D, K2, Magnesium and Zinc.

Human milk oligosaccharides (HMOs) arise from tightly regulated glycosylation pathways and exert pleiotropic effects on infant immune, microbial, and neurodevelopmental trajectories.

Vitamin D influences gene transcription and cellular metabolism, yet its potential role in mammary glycosylation remains unexplored.

Who Took Part

The age groups tagged for this paper are adults, women only.

How the Study Was Run

The researchers set it up as a randomized and pilot study.

The participants were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

It is described as a pilot, a small early test of whether a larger Vitamin D, K2, Magnesium and Zinc study would be practical.

The researchers performed a post hoc analysis of two clinical studies: the NICHD vitamin D lactation randomized controlled trial (2005-2012) and the Lactation Immune Trial pilot (n = 88).

Serum 25-hydroxyvitamin D [25(OH)D, vitamin D status] and 19 HMOs concentrations were measured at 1 and 4 months postpartum.

Secretor status was defined by presence of 2'-fucosyllactose.

What Was Measured

The subject headings attached to it are Milk, Human, Oligosaccharides, Vitamin D, Lactation, Glycosylation and Trisaccharides.

The authors tagged it with the keywords 25-hydroxyvitamin D, Breastfeeding, Fucosyltransferase, Human milk oligosaccharide and Secretor.

What This Means in Plain Language

The paper is a randomized and pilot study of Vitamin D, K2, Magnesium and Zinc.

Its findings take up roughly 6 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2026 (The Journal of steroid biochemistry and molecular biology), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.